InMode – Investment Presentation

The Israeli high-technology medical devices and equipment industry has produced a few success stories, with InMode now leading this sector. 

We believe InMode is a high-quality aesthetics device company with industry-leading results. As of its last quarterly update, Q2 2021, InMode had three segments Minimally-Invasive (70%), Hands-free (23%) and Noninvasive (7%). -% of revenue sales. 

InMode’s 2020 products like Morpheus8 and Evoke have outperformed initial expectations. Their co-founders, Moshe Mizrahy and Dr Michael Kerindel, previously founded Syneron and have established a track record of success. The current executive team has over 15 years of medical aesthetics industry experience.

In the investment presentation below, we detail our investment outlook for InMode. 

Related Posts